About TONACEA
In the autumn of 2004, by the Yinding Bridge in Houhai, Beijing. Zengjiang Cheng discussed on “How to become an excellent drug R&D management talent”with several partners engaged in drug R&D . They reached a consensus on the urgency of expanding vision and refining, and decided to organize a salon for fellow travelers to discuss and embrace warmth together. The name of TONACEA came from the bar "Hutong Xie Yi", which was covered by weeping willow then, and "Tong Xie Yi" jumped out. This is "TONGXIEYI", which named for "TONACEA" in English.
Following the theme of drug R&D, TONGXIEYI Salon has rapidly grown into a forum organization with its original idea of "Gathering the first class and seeking insights" . The topics covered R&D technology, technology management and technology life. The area has also extended from Beijing to Suzhou. Many leading talents of novel drugs have come to TONACEA forum. More>>

Since TONACEA established in 2004, We have held more than 120 professional forums. At the same time, TONACEA has been invited to plan and operate annual biomedical industry innovation conferences for governments in Suzhou, Wuxi, Beijing, Shenzhen, Guangzhou, Zhengzhou and other places. Thematic training such as "Consistency of Generic Drugs", "File simultaneously in China and the United States", "Valuation of Novel Drugs" and "Clinical case analysis" have become classic training activities in the industry. Continuous accumulation has also resulted in the annual industry brand conference of TONACEA "Global Conference on Biopharma Frontier Technology ".
At the beginning of 2020, TONACEA will create a series of brand activities called "TONACEA President Meeting Room", bringing together the CEOs/ presidents of member institutions to enjoy the landscape and build the Co-founding Tech-life, together arrive at a poetric future of Chinese novel drugs.
Journy
Together arrive at a poetric future of Chinese novel drugs


Since 2013, based on the "Highland of China's Novel drug thought", TONACEA has started to build a new media matrix, and has carried out multi-level reports on frontier technology, policies and regulations, capital markets, industrial transformation, innovative figures and other bio-innovation related fields. At present, TONACEA continues to serve more than 500 customers.
On wechat, TONACEA accounts have accumulated more than 200,000 subscribers, mainly including leaders of government, parks, listed companies, innovative pharmaceutical enterprises, investment institutions, and front-line practitioners. In addition, TONACEA has entered community platforms such as Snowball, Zhihu and Weibo. TONACEA's brand exposure has exceeded 24 million.

XIEYI Live Stream continues to launch forum in the cloud. It provides an online way to gain insight into the industry dynamics in the first time, to lead the industry and empower enterprises.
XIEYI Live Stream is committed to providing one-stop service solutions for Chinese biomedical enterprises. It covers a variety of types, such as conferences with more than thousands of people, personal interview, promotion and release, XIEYI live class and so on.
The platform has strong advantages: top experts, first class; XIEYI planning, high level; Media matrix, full-line promotion and distribution; Professional hosting, warm service; Wechat community, targeted promotion; Standardized process, professional technology. TONACEA can provide whole-process control before, during and after live broadcasting.
Provide service for more than 200 institutions
Operate with governmental parks
Recommendation
About TONACEA
In the autumn of 2004, by the Yinding Bridge in Houhai, Beijing. Zengjiang Cheng discussed on “How to become an excellent drug R&D management talent”with several partners engaged in drug R&D . They reached a consensus on the urgency of expanding vision and refining, and decided to organize a salon for fellow travelers to discuss and embrace warmth together. The name of TONACEA came from the bar "Hutong Xie Yi", which was covered by weeping willow then, and "Tong Xie Yi" jumped out. This is "TONGXIEYI", which named for "TONACEA" in English.
Following the theme of drug R&D, TONGXIEYI Salon has rapidly grown into a forum organization with its original idea of "Gathering the first class and seeking insights" . The topics covered R&D technology, technology management and technology life. The area has also extended from Beijing to Suzhou. Many leading talents of novel drugs have come to TONACEA forum.
In November 2012, with the mission of "Gathering novel drug R&D talents with vision and sense of mission. Exploring the scientific laws and business models of novel drug R&D. Promoting the healthy development of China's pharmaceutical industry", TONACEA Novel Drug Elite Club was founded in Suzhou. Professor Xun Zhu, an immunologist, was appointed as the first director, followed by Ruyi He, the former chief scientist of CDE.
In October 2014, the 10th anniversary of TONACEA was held in Suzhou with the theme of "Finding the Soul of China's Novel Drugs". TONACEA began to operate a professional team and emerge in the industry.
So far, TONACEA has held more than 120 forums, and has been invited to plan and operate annual biomedical industry innovation conferences for governments in Suzhou, Wuxi, Beijing, Shenzhen, Guangzhou, Zhengzhou and other places. Thematic training such as "Consistency of Generic Drugs", "File simultaneously in China and the United States", "Valuation of Novel Drugs" and "Clinical case analysis" have become classic training activities in the industry. Continuous accumulation has also resulted in the annual industry brand conference of TONACEA "Global Conference on Biopharma Frontier Technology ".
Every medical policy change, every industry hot spots emerge, TONACEA will be brave to stand at the head of the tide, gather first-class talents in the first time, for the industry leadership, to empower enterprises . In the medical circle, TONACEA has already become the spiritual home of many novel drug R&D talents, as well as one of the important birthplaces of novel drugs thought in China.